Clinical Trials Logo
  1. Home
  2. Prostate Cancer Recurrent
  3. NCT02562131

PET-MR-PSA Prostate Cancer Recidive Study — PET-MR-PSA  

Prostate Cancer Recurrent Clinical Trial

Official title:
18F-Fluciclovine PET/MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

Clinical Trial Summary

Simultaneous PET/MRI has the potential to improve the detection accuracy in recurrent prostate cancer, since it combines the excellent soft-tissue contrast of MRI with the high molecular sensitivity of PET in a single imaging session. The aim of this study is to evaluate the sensitivity and specificity of simultaneous 18F-Fluciclovine PET/MRI for detection of recurrent prostate cancer.

Clinical Trial Description

The patients follow standard treatment and follow-up after the PET/MRI exam, which will be determined by the patient's treating urologist and/or oncologist. Data from histopathology, clinical follow-up and follow-up imaging will be collected to establish a reference standard that defines the presence or absence of disease for each patient. The imaging findings will be compared with the reference standard to assess the sensitivity and specificity. The diagnostic accuracy of combined PET/MRI and MRI-only (the current clinical standard) will be compared. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02562131
Study type Observational
Source Norwegian University of Science and Technology
Contact
Status Active, not recruiting
Phase
Start date September 2015
Completion date December 2027
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Recruiting NCT05848011 - A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer Phase 2
Completed NCT04134130 - The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer N/A
Recruiting NCT03507595 - Evaluation of the Metastasis and Recurrence of Prostate Cancer
Active, not recruiting NCT04983628 - Molecular Profiling in Prostate Cancer
Completed NCT03739684 - Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer Phase 3
Recruiting NCT04686188 - Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer
Active, not recruiting NCT04114825 - Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer Phase 2
Recruiting NCT05646550 - Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer Phase 1
Not yet recruiting NCT04876755 - MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer Phase 2
Recruiting NCT01938339 - Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer N/A
Completed NCT01857037 - Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI N/A
Active, not recruiting NCT03444844 - Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer Phase 1/Phase 2
Completed NCT04102553 - F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence Phase 3
Completed NCT03443609 - Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer N/A
Recruiting NCT05036226 - COAST Therapy in Advanced Solid Tumors and Prostate Cancer Phase 1/Phase 2
Completed NCT04324983 - Identification of Predictive Biomarkers N/A
Completed NCT02176161 - Metformin Prostate Cancer Adjuvant Trial Phase 2
Active, not recruiting NCT04734184 - A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer Phase 3
Not yet recruiting NCT04312191 - Using Meditation for Oncology Anxiety N/A